Thompson Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

Thompson Investment Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14	Hold	13	–	–	﹤0.01%	502
2026 Q1	$23	Hold	13	–	–	﹤0.01%	496
2025 Q4	$23	Hold	13	–	–	﹤0.01%	520
2025 Q3	$30	Hold	13	–	–	﹤0.01%	516
2025 Q2	$26	Hold	13	–	–	﹤0.01%	487
2025 Q1	$21	Hold	13	–	–	﹤0.01%	480
2024 Q4	$24	Hold	13	–	–	﹤0.01%	493
2024 Q3	$75	Hold	13	–	–	﹤0.01%	493
2024 Q2	$105	Hold	13	–	–	﹤0.01%	489
2024 Q1	$180	Hold	13	–	–	﹤0.01%	503
2023 Q4	$81	Hold	13	–	–	﹤0.01%	416
2023 Q3	$61	Hold	13	–	–	﹤0.01%	403
2023 Q2	$71	Hold	13	–	–	﹤0.01%	402
2023 Q1	$130	Buy	+13	New	+$222	﹤0.01%	393

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Thompson Investment Management's INO Position: Q2 2026 in Review

Thompson Investment Management held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 13 shares worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #502.

Thompson Investment Management first reported a position in INO in Q1 2023 and has held it in 14 quarters since. The position peaked at $180 in Q1 2024. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Thompson Investment Management held 13 shares of Inovio Pharmaceuticals worth $14 as of Q2 2026.
Thompson Investment Management left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Thompson Investment Management's portfolio in Q2 2026, its #502 holding.
Thompson Investment Management first reported a position in Inovio Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
Thompson Investment Management's Inovio Pharmaceuticals position peaked at $180 in Q1 2024.
103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.